Articles Archive - Page 2 of 4 - Bioduro

Let's talk
Contact us

2020.04.23

BioDuro Breaks Ground on 300,000 sq ft Facility in Jiangsu China

SAN DIEGO—On April 17, 2020, the groundbreaking ceremony for BioDuro’s...

Read more

September 2018
Expanded Nucleoside and Nucleotide Capabilities at BioDuro
September 2018
Diastereomeric Salt Resolution for Separating Chiral Compounds on Larger Scale at BioDuro
August 2018
Using the Dr. Jekyll of Chemical Compounds to Advance Drug Synthesis
June 2018
Production of Recombinant Proteins at BioDuro
March 2018
BioDuro Collaboration with Pfizer Inc. Leads to Creation of a Shelf-Stable Fluorosulfation Reagent
March 2018
BioDuro Completes Acquisition of Molecular Response to Accelerate Translational Oncology Capabilities
January 2018
BioDuro Announces Cooperation Agreement with Porton Pharma Solutions
March 2017
BioDuro launches humanized tumor microenvironment, three-dimensional drug screening and patient-derived xenograft verification platform: hTME-3DX Screen and Verify™
November 2016
New Strategies Required to Meet Changing Needs in the Analytical Services Market